参考文献

1. Bergman M. Presented at the 1-hour plasma glucose as a novel biomarker for detecting dysglycaemia, complications and mortality. 3 October. EASD Annual Meeting 2023.

2. Buysschaert M, et al. Diabetes Metab. 2022; 48(6): 101395.

3. Jae-Seung Yun JS, et al. 250 - Risk of cardiovascular and mortality outcomes in Korean type 2 diabetes and prediabetes: a nationwide population-based cohort study. OP 42 Risk factors and biomarkers of CVD. EASD Annual Meeting 2023.

4. Zhang L, et al. Lancet Diabetes Endocrinol. 2023; 11(8): 567-577.

5. Bao LX, et al. J Matern Fetal Neonatal Med. 2021; 34(16): 2741-2753.

6. Paavilainen E, et al. Diabetes Res Clin Pract. 2023; 202: 110780.

7. Gómez-Banoy N, et al. Nat Med. 2019; 25(11): 1739-1747.

8. Fidelma Dunne. Metformin for the management of GDM: friend or foe? Presented at DPSG SYMPOSIUM. 3 October. EASD Annual Meeting 2023.

9. Feig DS, et al. Lancet Diabetes Endocrinol. 2020; 8(10): 834-844.

10. Abolhassani N, et al. BMJ Open Diabetes Res Care. 2023; 11(1): e002919.

11. Kjerpeseth LJ, et al. Diabetes Care. 2023; 46(8): 1556-1564.

12. Feig DS, et al. Lancet Diabetes Endocrinol. 2023; 11(3): 191-202.

13. Brand KMG, et al. BMJ Open Diabetes Res Care. 2022; 10(1): e002363.

14. Triggle CR, et al. Metabolism. 2022; 133: 155223.

往 期 回 顾

声明：本文仅供医疗卫生专业人士了解最新医药资讯参考使用，不代表本平台观点。该等信息不能以任何方式取代专业的医疗指导，也不应被视为诊疗建议，如果该信息被用于资讯以外的目的，本站及作者不承担相关责任。